68Ga-PSMA PET/CT Uptake in the Ureter Caused by Ligand Expression in Urothelial Cancer

Research output: Contribution to journalJournal articleCommunication

6 Citations (Scopus)

Abstract

68Ga-PSMA PET/CT has become a well-established imaging modality to detect prostate cancer (PCa) metastases in biochemical recurrence. Despite its claimed specificity for PCa, 68Ga-PSMA uptake in tissues unrelated to PCa, particularly in the neovascular tissue of other cancers, has been reported in numerous studies. A 73-year-old man underwent 68Ga-PSMA PET/CT for biochemical recurrence of PCa 7 years after radical prostatectomy. The 68Ga-PSMA PET/CT showed 1 lesion with PSMA uptake in the distal left ureter. Histology revealed a low-grade noninvasive papillary urothelial carcinoma. By immunohistochemistry, PSMA expression was observed in the neoplastic urothelial cells and in the vessels of the papillary structures.

Original languageEnglish
JournalClinical Nuclear Medicine
Volume45
Issue number1
Pages (from-to)e43-e45
Number of pages2
ISSN0363-9762
DOIs
Publication statusPublished - Jan 2020

Keywords

  • Ga-PSMA
  • PET/CT
  • PSMA expression
  • prostate cancer
  • urothelial cancer

Fingerprint

Dive into the research topics of '68Ga-PSMA PET/CT Uptake in the Ureter Caused by Ligand Expression in Urothelial Cancer'. Together they form a unique fingerprint.

Cite this